Literature DB >> 34189598

[Single dose of 24 Gy or 3-fraction SBRT regimen in the treatment of oligometastatic cancer? : A phase III multi-center trial].

Hossein Hemmatazad1, Etienne Mathier1, Daniel M Aebersold1, Mohamed Shelan2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34189598     DOI： 10.1007/s00066-021-01806-0

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  13 in total

1.  International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery.

Authors:  Brett W Cox; Daniel E Spratt; Michael Lovelock; Mark H Bilsky; Eric Lis; Samuel Ryu; Jason Sheehan; Peter C Gerszten; Eric Chang; Iris Gibbs; Scott Soltys; Arjun Sahgal; Joe Deasy; John Flickinger; Mubina Quader; Stefan Mindea; Yoshiya Yamada
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-19       Impact factor: 7.038

2.  Reliability analysis of the epidural spinal cord compression scale.

Authors:  Mark H Bilsky; Ilya Laufer; Daryl R Fourney; Michael Groff; Meic H Schmidt; Peter Paul Varga; Frank D Vrionis; Yoshiya Yamada; Peter C Gerszten; Timothy R Kuklo
Journal:  J Neurosurg Spine       Date:  2010-09

Review 3.  Response assessment after stereotactic body radiotherapy for spinal metastasis: a report from the SPIne response assessment in Neuro-Oncology (SPINO) group.

Authors:  Isabelle Thibault; Eric L Chang; Jason Sheehan; Manmeet S Ahluwalia; Matthias Guckenberger; Moon-Jun Sohn; Samuel Ryu; Matthew Foote; Simon S Lo; Alexander Muacevic; Scott G Soltys; Samuel Chao; Peter Gerszten; Eric Lis; Eugene Yu; Mark Bilsky; Charles Fisher; David Schiff; Michael G Fehlings; Lijun Ma; Susan Chang; Edward Chow; Wendy R Parelukar; Michael A Vogelbaum; Arjun Sahgal
Journal:  Lancet Oncol       Date:  2015-12       Impact factor: 41.316

4.  Vertebral Compression Fracture After Spine Stereotactic Body Radiation Therapy: A Review of the Pathophysiology and Risk Factors.

Authors:  Salman Faruqi; Chia-Lin Tseng; Cari Whyne; Majed Alghamdi; Jefferson Wilson; Sten Myrehaug; Hany Soliman; Young Lee; Pejman Maralani; Victor Yang; Charles Fisher; Arjun Sahgal
Journal:  Neurosurgery       Date:  2018-09-01       Impact factor: 4.654

Review 5.  The diagnostic imaging of bone metastases.

Authors:  Walter Heindel; Raphael Gübitz; Volker Vieth; Matthias Weckesser; Otmar Schober; Michael Schäfers
Journal:  Dtsch Arztebl Int       Date:  2014-10-31       Impact factor: 5.594

Review 6.  Imaging response assessment following stereotactic body radiotherapy for solid tumour metastases of the spine: Current challenges and future directions.

Authors:  Siobhra O'Sullivan; Ronan McDermott; Maeve Keys; Maeve O'Sullivan; John Armstrong; Clare Faul
Journal:  J Med Imaging Radiat Oncol       Date:  2020-04-15       Impact factor: 1.735

7.  Radiological changes on CT after stereotactic body radiation therapy to non-spine bone metastases: a descriptive series.

Authors:  Nicholas Chiu; Linda Probyn; Srinivas Raman; Rachel McDonald; Ian Poon; Darby Erler; Drew Brotherston; Hany Soliman; Patrick Cheung; Hans Chung; William Chu; Andrew Loblaw; Nemica Thavarajah; Catherine Lang; Lee Chin; Edward Chow; Arjun Sahgal
Journal:  Ann Palliat Med       Date:  2016-04

8.  Osseous Pseudoprogression in Vertebral Bodies Treated with Stereotactic Radiosurgery: A Secondary Analysis of Prospective Phase I/II Clinical Trials.

Authors:  B Amini; C B Beaman; J E Madewell; P K Allen; L D Rhines; C E Tatsui; N M Tannir; J Li; P D Brown; A J Ghia
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-22       Impact factor: 3.825

Review 9.  Stereotactic spine radiosurgery: Review of safety and efficacy with respect to dose and fractionation.

Authors:  Michael Huo; Arjun Sahgal; David Pryor; Kristin Redmond; Simon Lo; Matthew Foote
Journal:  Surg Neurol Int       Date:  2017-02-20

10.  Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.

Authors:  Yining Gong; Lingyi Xu; Hongqing Zhuang; Liang Jiang; Feng Wei; Zhongjun Liu; Yan Li; Miao Yu; Kaiwen Ni; Xiaoguang Liu
Journal:  Cancer Med       Date:  2019-09-05       Impact factor: 4.452
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.